Early cancer detection: the Argentine startup that secured US$4.2 million and is preparing for its Series A funding round.

Oncoliq in Forbes

Oncoliq was featured by Forbes for the development of its early cancer detection technology and the startup’s journey from scientific research to becoming a growing biotechnology company. The article traces the path of its co-founders from the laboratory to building the company, and explores the development of its blood test, its growth strategy, and the company’s next steps

Read the full article See more news